No profile data available.
CytoMed Therapeutics Limited (GDTC) is a healthcare company in the biosample preservation services industry, based in Singapore, Singapore, with about 42 full-time employees.
It reported revenue of 324,387 SGD for fiscal year 2025, up 366.7% from fiscal year 2024, and net income of -3.98 million SGD. Its market capitalization was $10.62 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
CytoMed Therapeutics Limited, a clinical stage biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore.
CytoMed Therapeutics reported 324,387 SGD in revenue for fiscal year 2025, up 366.7% from $69,501 in fiscal year 2024.
$10.62 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biosample preservation services) include Cryo-Cell International, Inc. (CCEL).